Results 121 to 130 of about 3,492 (143)

Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case series. [PDF]

Front Oncol
Li Q, Ji J, Wu Y.
europepmc   +1 more source

Clonally Distinct FLT3-TKD Mutations in Host and Donor-Derived AML After Double Cord Blood Transplant: A Case Report. [PDF]

EJHaem
Rojansky RB, Law LY, Zhang BM, Kennedy VE.   +3 more
europepmc   +1 more source

Multi omics and mechanistic investigation reveals CBFB as a prognostic biomarker in gastric cancer. [PDF]

Discov Oncol
Zhou Q, Wang L, Wang MH, Yuan YH, Guo J, Chen B, Zhang JZ, Wang MZ.   +7 more
europepmc   +1 more source

Whole genome sequencing in acute myeloid leukemia. [PDF]

Haematologica
Haferlach T.
europepmc   +1 more source

Tandem Double Inversion Resolves the Structural Paradox Underlying Recurrent KAT6A::NCOA2 Fusion in Acute Myeloid Leukemia. [PDF]

Genes Chromosomes Cancer
Nagai J, Yoshida S, Teshima T, Onozawa M.   +3 more
europepmc   +1 more source

Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts. [PDF]

Noncoding RNA
Arza-Apalategi S, Gilissen D, van der Grinten AC, van den Oever SN, van den Akker EB, Griffioen M, Jansen JH, Martens JHA, Marneth AE, van der Reijden BA.   +9 more
europepmc   +1 more source

Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 [PDF]

Cell, 1996
The fusion oncogene CBFB–MYH11 is generated by a chromosome 16 inversion in human acute myeloid leukemia subtype M4Eo. Mouse embryonic stem (ES) cells heterozygous for this oncogene were generated by inserting part of the human MYH11 cDNA into the mouse ...
Nancy A Speck, Anthony Wynshaw-Boris, Cisca Wijmenga   +2 more
exaly   +2 more sources

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion

British Journal of Haematology, 2002
We have designed a real-time CBFB-MYH11 reverse transcription polymerase chain reaction (RT-PCR) assay to quantify minimal residual disease (MRD) in patients with inv(16)-positive acute myeloid leukaemia (AML).
Martijn H Breuning, Bert A van der Reijden, Georgine E de Greef   +2 more
exaly   +2 more sources

RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB- MYH11 transcripts

Blood, 1995
As acute nonlymphocytic leukemia (ANLL) with inv(16) (p13q22) or t(16;16)(p13;q22) has been shown to result from the fusion of transcription factor subunit core binding factor (CBFB) to a myosin heavy chain (MYH11), we sought to design methods to detect ...
Beverstock, G.C., Lombardo, M., Giles, R.H., Wessels, H.W., Bellomo, M.J., Dauwerse, H.G., Mühlematter, D., van der Reijden, B.A., van Ommen, G.J., Hagemeijer, A., Breuning, M.H.   +10 more
exaly   +2 more sources